Lamivudine as initial treatment for chronic hepatitis B in the United States.

MLA

Dienstag, J. L., et al. “Lamivudine as Initial Treatment for Chronic Hepatitis B in the United States.” The New England Journal of Medicine, vol. 341, no. 17, Oct. 1999, pp. 1256–63. EBSCOhost, https://doi.org/10.1056/NEJM199910213411702.

APA

Dienstag, J. L., Schiff, E. R., Wright, T. L., Perrillo, R. P., Hann, H. W., Goodman, Z., Crowther, L., Condreay, L. D., Woessner, M., Rubin, M., & Brown, N. A. (1999). Lamivudine as initial treatment for chronic hepatitis B in the United States. The New England Journal of Medicine, 341(17), 1256–1263. https://doi.org/10.1056/NEJM199910213411702

Chicago

Dienstag, J L, E R Schiff, T L Wright, R P Perrillo, H W Hann, Z Goodman, L Crowther, et al. 1999. “Lamivudine as Initial Treatment for Chronic Hepatitis B in the United States.” The New England Journal of Medicine 341 (17): 1256–63. doi:10.1056/NEJM199910213411702.